Skip to main content

Palasis Maria

Director | President &CEO

2 companies

Insider Signal Score

65
Good
Trades Analyzed
4
12M Win Rate
-
Avg 3M Return
+50.9%
Avg 12M Return
-

Palasis Maria is a President &CEO at Lyra Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 6 sells.

Estimated insider holdings value: $867K based on current market prices.

Holdings by Company

LYRAJan 6, 2026
Current Shares1.10M
Value$658.0K
Net Activity-3,267
Bought: 0Sold: 3.3K
BBNXJan 13, 2026
Current Shares12.4K
Value$209.1K
Net Activity-2,812
Bought: 0Sold: 2.8K

Transaction History

Showing 4 filings
DateTickerRoleTypeSharesPriceValueChg%3M12MSEC
Jan 6, 2026
LYRA
Lyra Therapeutics, Inc.
President &CEOSell1,702$3.36$5,725.53-0.2%-85.4%-
Dec 1, 2025
BBNX
Beta Bionics, Inc.
DirectorSell1,406$29.55$41,552.17-7.5%-57.6%-
Oct 31, 2025
BBNX
Beta Bionics, Inc.
DirectorSell1,406$26.91$37,833.85-6.6%-45.7%-
Jul 10, 2025
LYRA
Lyra Therapeutics, Inc.
President &CEOSell1,565$8.91$13,944.15-0.1%-14.8%-